Medical Device Regulatory Framework and Clinical Evaluation

Global regulatory frameworks for medical devices are designed to ensure safety, performance and clinical effectiveness throughout the device lifecycle. Key jurisdictions include the European Union’s Medical Device Regulation (MDR) and the US Food and Drug Administration’s regulations. Devices are classified by risk based on intended purpose, invasiveness and duration of contact, with higher-risk devices subject to more stringent conformity assessment by notified bodies or equivalent authorities. Manufacturers must implement a quality management system, compile technical and clinical documentation, and demonstrate compliance through pre-market review, clinical investigations or literature-based clinical evaluation. Post-market surveillance and post-market clinical follow-up activities provide real-world data to detect and mitigate emerging risks. Recent expansions to cover software as a medical device, artificial intelligence tools and connected health solutions have prompted updates to classification rules, evidence requirements and unique device identification systems. Harmonisation of standards and global collaboration aim to reduce duplication, expedite patient access and maintain high safety standards, while accommodating innovation from small- and medium-sized enterprises to large multinational corporations.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Medical Device Regulatory Framework and Clinical Evaluation publication trend

The graph below shows the total number of articles in medical device regulatory framework and clinical evaluation across all publications each year (not limited to Nature Index journals).

Technical terms

Classification: The process of assigning a device to a risk category based on intended use and invasiveness.

Clinical Evaluation: Systematic assessment of clinical data to verify device safety and performance.

Conformity Assessment: Procedures for demonstrating that a device meets regulatory requirements, often involving notified bodies.

Notified Body: An independent organisation designated by EU Member States to assess conformity of devices.

Post-Market Surveillance (PMS): Continuous monitoring of device performance and safety after market launch.

Unique Device Identifier (UDI): A code system that uniquely identifies medical devices through distribution and use.

References

1. Exploring Impediments Imposed by the Medical Device Regulation EU 2017/745 on Software as a Medical Device. JMIR Medical Informatics (2024).
2. The European Medical Device Regulation–What Biomedical Engineers Need to Know. IEEE Journal of Translational Engineering in Health and Medicine (2022).
3. The Challenges for Manufacturers of the Increased Clinical Evaluation in the European Medical Device Regulations: A Quantitative Study. Therapeutic Innovation & Regulatory Science (2023).
4. Challenges faced by manufacturers with clinical evaluation under the new European Medical Device Regulations. Cogent Engineering (2023).